CLASS II Drug recall · Reported 7 Jun 2023 · FDA Enforcement Report

Sodium Chloride 0.9% Injection, USP bags recalled

Fresenius Medical Care Holdings is recalling Sodium Chloride 0.9% Injection, USP bags per, distributed in North Carolina, South Carolina, Virginia. The recall was initiated on 23 May 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot # 23AU05030, Exp 01/13/2024; 23AU05035, Exp 01/15/2024
NDC49230-300
Quantity recalled53,424 bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0777-2023
FDA event ID
92403
Recalling firm
Fresenius Medical Care Holdings, Waltham, MA
Manufacturer
Fresenius Medical Care Renal Therapies Group, LLC
Classification
Class II
Status
Terminated
Recall initiated
23 May 2023
FDA classified
1 Jun 2023
Reported
7 Jun 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

23 May 2023Recall initiated by company
1 Jun 2023Classified by FDA+9 days
7 Jun 2023Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

Sodium Chloride 0.9% Injection, USP, 1000 mL bags, 12 bags per carton, Rx only, Fresenius Medical Care North America, Waltham, MA 02451, NDC # 49230-300-10

Where it was distributed

Product was distributed to 32 clinics in SC, NC and VA.

North CarolinaSouth CarolinaVirginia

Questions about this recall

Why was it recalled?

Lack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging.

Which lots are affected?

Lot # 23AU05030, Exp 01/13/2024; 23AU05035, Exp 01/15/2024

Where was it sold?

Product was distributed to 32 clinics in SC, NC and VA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Fresenius Medical Care Holdings

All 165

Other Sodium Chloride recalls

All 132